FindTrial
Sign In

Glucose metabolism in patients with neurological/neuromuscular diseases.

Glucose metabolism in patients with neurological/neuromuscular diseases.

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2006-004749-40-BE
Enrollment
Unknown
Registered
2006-10-17
Start date
2006-11-20
Completion date
Unknown
Last updated
2012-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with neurological/neuromuscular diseases

Interventions

Pharmaceutical Form:

Sponsors

Pediatrics
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Spina bifida (age 8 - adult age) + insuline resistance or fat mass > 30% Duchenne muscular dystrophy (age 8 - adult age) + insuline resistance or fat mass >30% SMA (age 8 - adult age) + insuline resistance or fat mass >30% Are the trial subjects under 18? yes Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: renal failure

Design outcomes

Primary

MeasureTime frame
Main Objective: prevalence of impaired glucose tolerance and cardiovascular risk factors. Evaluate effect of treatment with Metformin.;Secondary Objective: ;Primary end point(s): Oral glucose tolerance test Dexa sca—

Countries

Belgium

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026